Cure Leukemia: Le Tour Meets Character

Ready for another good news story from the 2021 Tour de France?

The Cure Leukemia peloton set out with two goals. Complete the entire Tour route of some 2,200 miles in 21 days – the same as the pro cyclists.  And raise £1-million ($1.4 million) for leukemia research in the United Kingdom, specifically for the Trials Acceleration Programme (TAP). The Cure Leukemia team is not composed of trained cyclists. It is made up of men and women of varying ages (some older than 60), and of varying athletic ability.   Many riders are cancer survivors. 

The Cure Leukemia Team was successful on all fronts.  They surpassed their financial goal.  And they completed the ride in 21 days.   Can you say “knackered”?  Imagine the impact on cancer research these 18 amateur cyclists have had.  

Geoff Thomas, the leader and a driving force for the entire endeavor, survived chronic myeloid leukemia 18 years ago.  A year earlier, Thomas had retired from a distinguished career as an English football player.   Given only three months to live he defied the odds, thanks to an experimental TAP’s treatment and transplant from his sister.   This marks Geoff’s fifth time riding the tour route. Just before the 2021 Cure Leukemia ride began, the Queen awarded Geoff the prestigious MBE (Member of the Most Excellent Order of the British Empire).

Cure Leukemia is a UK-based charitable organization and an official partner of the Tour de France.

Once again ordinary people with a common purpose triumph.

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply